Kentucky 2024 Regular Session

Kentucky House Bill HB211

Introduced
1/9/24  

Caption

AN ACT relating to controlled substances.

Impact

If passed, HB 211 will significantly alter how substance use is managed within the state, shifting focus from punitive measures toward supportive and preventive measures. The bill creates legal protections for individuals involved in these harm reduction centers, shielding them from criminal charges and civil liability related to the operation of the centers, as long as they comply with the regulations set forth by the Department for Public Health. This encourages community participation and investment in public health initiatives, particularly in areas heavily affected by substance use issues.

Summary

House Bill 211 aims to address the growing concern of substance use and overdose deaths by establishing harm reduction centers throughout Kentucky. The bill mandates the Department for Public Health to create these centers that will provide essential services such as health screenings, overdose prevention, and substance checking services in a supportive environment. The intent of this legislation is not just to mitigate the immediate risks associated with substance use but also to promote recovery by offering comprehensive services, thereby enhancing public health and safety.

Sentiment

The sentiment around HB 211 is generally positive among public health advocates and those who support harm reduction strategies. Proponents argue that this approach not only saves lives but also addresses the underlying public health crisis associated with addiction. However, there is notable contention from opponents who worry about the potential normalization of drug use and the moral implications of allowing consumption sites. This bill ignites a debate over how society tackles narcotics use and addiction, balancing public health concerns with community ethics and safety.

Contention

The primary contention surrounding HB 211 involves the perception and acceptance of harm reduction approaches. While advocates emphasize the necessity of such centers to provide relief and support to individuals struggling with substance use, critics express concerns about the risks of enabling drug use and undermining law enforcement efforts. The efficacy and potential consequences of implementing harm reduction centers in various communities remain a hot topic, with discussions reflecting broader societal views on addiction and treatment.

Companion Bills

No companion bills found.

Previously Filed As

KY SB2418

Relating To Controlled Substances.

KY HB1549

Relating To Controlled Substances.

KY HB1482

Related To Controlled Substances.

KY HB680

AN ACT relating to controlled substances.

KY SB2250

Relating To The Promotion Of Controlled Substances.

KY SB236

Relating to controlled substances; and declaring an emergency.

KY HB2365

Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substances.

KY H0309

Controlled Substances

KY HB637

Possession of residue of a controlled substance unlawful; penalties exceptions.

KY HB2083

Relating To The Promotion Of Controlled Substances.

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.